ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AEMD Amundi Luxembourg SA

51.4716
0.0612 (0.12%)
19:04:08 - Realtime Data
Name Symbol Market Type
Amundi Luxembourg SA TG:AEMD Tradegate Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.0612 0.12% 51.4716 51.131 51.5502 51.6219 51.4421 51.5012 1,199 19:04:08

Aethlon Medical Discloses Live Webcast of Today's BIOCOM Presentation

26/10/2009 9:00am

PR Newswire (US)


Amundi Luxembourg (TG:AEMD)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Amundi Luxembourg Charts.
SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) disclosed that today's presentation at the 4th Annual BIOCOM Investor Conference will be webcast live today. The presentation by Aethlon Chairman and CEO, James A. Joyce will begin at 2 p.m. pacific time and can be accessed on an audio-only basis at: http://www.biocom.org/event/2009_Investor_Conference (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b) About BIOCOM BIOCOM is the largest regional life science association in the world, representing 550 member companies in Southern California. The association focuses on initiatives that position the region's life science industry competitively on the world stage, and on the development and delivery of innovative products that improve health and quality of life. This includes initiatives in capital formation, public policy, workforce development, and member services. For more information on BIOCOM or the Southern California biotechnology and medical device community, please visit the organization's website at http://www.biocom.org/. About Aethlon Medical Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at http://www.aethlonmedical.com/. Contacts: RedChip Companies, Inc. Jon Cunningham 1-800-733-2447, Ext. 107 Jim Joyce Chairman, CEO 858.459.7800 x301 Jim Frakes Senior VP Finance 858.459.7800 x300 http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b http://photoarchive.ap.org/ DATASOURCE: Aethlon Medical, Inc. CONTACT: Jon Cunningham of RedChip Companies, Inc., 1-800-733-2447, Ext. 107, , for Aethlon Medical, Inc.; or Jim Joyce, Chairman, CEO, +1-858-459-7800, ext. 301, , or Jim Frakes, Senior VP Finance, +1-858-459-7800, ext. 300, , both of Aethlon Medical, Inc. Web Site: http://www.aethlonmedical.com/ http://www.biocom.org/

Copyright

1 Year Amundi Luxembourg Chart

1 Year Amundi Luxembourg Chart

1 Month Amundi Luxembourg Chart

1 Month Amundi Luxembourg Chart

Your Recent History

Delayed Upgrade Clock